Simple ECG May Help Distinguish MDD From Bipolar Depression

Share this content:
Simple ECG May Help Distinguish MDD From Bipolar Depression
Simple ECG May Help Distinguish MDD From Bipolar Depression

TUESDAY, Nov. 28, 2017 (HealthDay News) -- Heart rate variability (HRV) and specific inflammatory biomarkers can differentiate major depressive disorder (MDD) from depression in bipolar disorder (BD), according to a study published online Oct. 5 in The World Journal of Biological Psychiatry.

Brandon Hage, M.D., from the Loyola University Chicago Stritch School of Medicine in Maywood, Ill., and colleagues quantified HRV and measured inflammatory biomarkers in 64 patients with MDD and 37 with BD.

The researchers found that, compared with BD subjects, MDD subjects had significantly higher baseline respiratory sinus arrhythmia (P = 0.05) and low-frequency (LF)-HRV (P < 0.01). BD subjects had significantly higher baseline levels of interleukin-10 (IL-10; P < 0.01) and monocyte chemoattractant protein-1 (P < 0.01) than MDD subjects. Baseline LF-HRV was significantly positively associated with baseline levels of IL-10 in the MDD group only (r = 0.47; P < 0.01).

"Reduced vagal tone and higher levels of inflammatory biomarkers may distinguish BD from MDD and reveal an underlying pathophysiology of depression involving autonomic nervous system dysfunction and chronic immune system dysregulation," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Lab  Companion Tests Perform Similarly for Oncology Analytes

Lab &#43; Companion Tests Perform Similarly for Oncology ...

Findings based on comparison of tests to diagnose oncology-related genetic variants

Ulixertinib Is Active in Patients With Advanced Solid Tumors

Ulixertinib Is Active in Patients With Advanced Solid ...

Responses occurred in patients with NRAS-, BRAF V600-, non-V600 BRAF-mutant solid tumors

Doctors Must Report on at Least 1 Patient, 1 Measure for MACRA

Doctors Must Report on at Least 1 Patient, ...

To avoid Medicare payment penalty in 2019, clinicians must report by Dec. 31, submit by Feb. 28

is free, fast, and customized just for you!

Already a member?

Sign In Now »